Monday, December 31, 2018

Quasi-Experimental Designs - One-group Intervention Studies


As I have addressed in a previous post, a clinical trial is defined as a research study in which one or more human participants are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.  My previous post provides a narrative about clinical trials that entail at least two independent groups.  This present post will describe clinical trials where one-group designs are utilized.

An intervention study in which one group of participants undergo repeated measurements before and after receiving one or more interventions is called a repeated measures design.  Because all participants receive the same interventions and the treatment effects are associated with changes within each participant, the repeated measures design is also referred to as a within-subjects design. 

In repeated measures designs, participants/subjects act as their own control, which is considered a study design strength in that the potential influence of individual differences is controlled.  For example, age and gender characteristics remain constant.  Therefore, changes in outcomes are inferred to be due to treatment effects and not differences between participants.  Using study participants are their own control provides the most equal “comparison group”.


 So, why is the randomized clinical trial consider the gold standard of intervention study designs?  Why isn’t the repeated measures design better?  One disadvantage of repeated measures studies is the possibility of practice effect or learning effect.  Study participants can learn how to perform better on an outcome measure through practicing or performing the outcome measurement on a repeated basis.  Consider a repeated measures intervention study in which the outcome measure is physical function.  Study participants may appear to show an improvement in physical function, but improvements could be due to participants learning how to perform the physical function test through repeated practice and not due to the treatment.

Another potential disadvantage of the repeated measures design is the carryover effect.  Study participants are at risk of experiencing a carryover effect when they are exposed to multiple forms of treatment.  Consider a study where one group of participants is exposed to three different balance training treatments (treatment A, treatment B, and treatment C) and the outcome measure is balance.  If balance is measured after each treatment, treatment A could have a carryover effect when balance is measured after the participants receive treatments B and C.  Thus, one cannot determine separate effects between treatments A, B, and C. 

Although practice effects and carryover effects are possible limitations of repeated measure designs, investigators can incorporate methods to control such limitations.  Methods to control for these limitations often depend on the nature of the independent (treatment) and dependent (outcome measure) variables.  I encourage readers of this blog to post comments on how to control for these limitations in difference types of studies!

Thursday, December 13, 2018

Experimental Designs - Clinical Trials


The National Institutes of Health has defined a clinical trial as a research study in which one or more human participants are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.  In terms of strength of study design, the randomized clinical trial is considered the strongest design to evaluate the cause-and-effect relationship of an intervention.

Clinical trials can be classified as either therapeutic or preventive.  Therapeutic trials investigate the effect of a treatment (independent variable) on an outcome (dependent variable).

Preventive trials assess if a treatment (independent variable) is effective in reducing the risk of developing a condition or disease (dependent variable).

Various experimental designs exist and I will be discussing different designs in future posts.  As for now, I will be discussing different types of clinical trial designs.

The “gold standard” of experimental designs is the randomized clinical trial (RCT).  The RCT design is also referred to as a pretest-posttest control group design.  This design is used to compare two or more groups that are created by random assignment, where one group receives the experimental treatment and the other group(s) serve as a control or comparison.  The different groups are sometimes referred to as treatment arms.  All groups undergo pre-testing before receiving treatment and post-testing afterwards.  During pre- and post-testing, outcomes data are collected from the study participants.  If the experimental group experiences a greater change in outcomes between pre- and post-testing than the control group, one can infer that the treatment caused an effect.

The information in previous posts on sampling, validity of intervention study design, and threats to study validity help to explain how the RCT is a strong study design.  Below is a flowchart that illustrates a RCT.


http://www.consort-statement.org/consort-statement/flow-diagram


The posttest-only control group design is the same as the pretest-posttest control group, except pre-testing does not occur in the experimental group nor control/comparison group.  In some situations, pre-testing is not possible.

Factorial designs are clinical trials that test the effect of more than one treatment, where potential interactions between the treatments are evaluated.

Randomized block designs are clinical trials where investigators wish to control for a possible extraneous variable that may influence differences between groups.  In such cases, homogeneous blocks of study participants.  For example, investigators may think that gender could influence the differences in effects between groups.  Each gender group could be randomly assigned to either the experimental group or the control group.  If 24 participants are included in the study (12 male and 12 female), the males could randomly assigned to groups (6 males in each group) and the female could be randomly assigned to groups (6 females in each group).  Gender can now be considered an independent variable and differences between males and females can be evaluated.

For more information about clinical trial designs, click on the following link.

Monday, December 3, 2018

Threats to Study Validity


Statistical Conclusion Validity
Statistical conclusion validity refers to the appropriate use of statistics for data analyses.  Examples of threats to statistical conclusion validity include:

1.  Low statistical power
2.  Violated assumptions of statistical tests
3.  Error rate
4.  Reliability of outcome measure procedures/tests

I have discussed reliability of outcome measures in a previous 
post.  I will be discussing statistical power, statistical test violations, and error rate in future posts.

Internal Validity
Internal validity refers to the potential for confounding factors to interfere with the relationship between the independent and dependent variables.  I have divided threats to internal validity into three categories.

1.  Single-Group Threats
2.  Multiple-Group Threats
3.  Social Threats  

Single-group threats include:  a) history, b) maturation, c) attrition, d) testing, e) instrumentation, and f) regression.

History is where the observed study results may be explained by events or experiences (confounding variables), other than the intervention/treatment.  For example, participation in other physical activities may effect the outcome of an exercise training study.

Maturation is a threat that is internal to the individual participant.  It is possible that mental or physical changes occur within the study participants that could account for the study results, simply due to the passage of time.  For example, a study that investigates the effect of a treatment on pain in patients with an acute orthopaedic injury may observe an improvement in pain due to the normal healing process and not the treatment.

Attrition (also referred to as drop-outs, withdraw, and experimental mortality) is a threat related to participants withdrawing from a study before it is completed.  If participants withdraw from a study, randomization is negatively impacted and data analyses cannot be performing on all pre-treatment and post-treatment data.

Testing (especially multiple testing) can have a potential effect on a dependent measure.  The effect of conducting multiple tests can result in improvement in an outcome measure that is due to a testing effect and not the effect of an intervention.  Because of this potential testing effect, researchers should use tests that are considered reliable.

Instrumentation is a possible threat if an instrument is unreliable and provides data that are unstable and prone to measurement error.  Observed changes seen between observation points (ie. pre-test and post-test) may also be due to changes in the testing procedure, including the instrument that is being used to collect data.

Regression (or regression toward the mean) is also related to the reliability of a test.  When an unreliable test is used for data collection, a statistical phenomenon sometimes occurs when extreme pre-intervention scores (for example, very high or very low scores) regress toward the group mean at post-intervention.  Again, a reliable test minimizes the threat of regression.  Previous research has identified this statistical phenomenon.


Multiple-group threats to internal validity are related to any variables other than the experimental intervention that can have an impact of the post-intervention difference in outcomes between the groups (sometimes referred to as selection interaction), making the groups not comparable.  Below is a description of different selection interaction threats.

The threat of selection-history is when one group of study participants has different experiences than the other group and these different experiences can influence the outcome of the study.  

Selection-maturation occurs when the experimental group experiences changes in the dependent variable at a different rate than the control or comparison group.  For example, a group of 2-year-old children are likely to experience a different rate of change in development than a group of 10-year-old children.

Selection-testing is when pre-intervention testing affects the groups differently.

Selection-instrumentation occurs when the test (outcome measurement procedures) are performed differently between the groups.

Selection-regression is a concern when participants are assigned to groups based on extreme scores.
Social threats to internal validity refer to the social pressures in the research context that can lead to post-intervention differences that are not directly caused by the treatment.  The following are possible social threats to internal validity.
Social threats can occur because study participants in one group are aware of the treatment that the other group is receiving.  Below are examples of socials threats.

Diffusion or imitation of treatment occurs when a comparison or control group learns about the treatment that the experimental group receives and tries to imitate the treatment.   

Compensatory rivalry is where the comparison or control group knows which intervention that the experimental group is receiving and develops a competitive attitude toward the experimental group.  

Compensatory equalization of treatments occurs when the one(s) who are delivering the experimental treatment administer the treatment to the control or comparison group because the treatment is considered more favorable for treating the study participants.

Resentful demoralization can be thought of the opposite of compensatory rivalry.   For example, the comparison or control group discovers the treatment that the experimental group is receiving.  In this case, instead of developing a rivalry, the comparison group becomes resentful and thus, post-intervention outcome scores may be lower.  Such an impact may be observed when subjective outcome measures (like a questionnaire) are being used.  This threat can result in false, exaggerated differences between groups, making the treatment appear more effective than it actually is.

Construct Validity of Cause and Effect
Construct validity are abstract behaviors or events than cannot be directly observed, but can impact the interpretation of the cause-and-effect relationship.  The threat related to construct validity that I would like to discuss is experimental bias.  This threat occurs when biases are introduced into a study by investigators or the study participants.  For example, participants may desire to fulfill the expectations of the investigators.  Thus, the participants "try harder" to perform better on post-intervention outcomes or adhere more strictly to the study protocol.  Investigators can incorporate this type of bias by making study participants aware of their expectations.  This phenomenon is often referred to as the Hawthorne effect.  Click on the following link for the history of the Hawthorne effect.

External Validity

The findings of a clinical research study must be translational to environments outside of a “lab” in order to be applicable.  External validity is related to the degree to which the results of a study can be generalized beyond the laboratory environment.  I will discuss three threats to external validity.

1.  Interaction of Treatment and Selection
2.  Interaction of Treatment and Setting
3.  Interaction of Treatment and History

When designing a clinical research study, investigators should include a sample of study participants from a target population.  The threat of interaction of treatment and selection concerns when the treatment does not apply to the entire target population.  For example, consider a study that includes a sample of patients with chronic low back pain.  The study findings may indicate that an intervention was effective for treating the sample of study participants.  However, sub-classifications of patients with chronic low back pain exist (patients have chronic low back pain with different causes).  So, the treatment may not be applicable for every patient with chronic low back pain.

The threat of interaction of treatment and setting occurs when the findings of a study cannot be applied to an environment outside the “lab”.  For example, a treatment may be shown to be effective in a controlled laboratory, but the clinical environment is significantly different and therefore, the results of the study cannot be observed at another site.  This threat can be minimized by replicating the study at multiple locations to determine if the study findings are observed in various settings.

The threat of interaction of treatment and history concerns the ability to generalize the findings of a study to different points in time.  For example, the findings of an older study may have indicated that a drug was effective for reducing hypertension, however the study did not control for confounding variables such as diet and exercise.  Since the results of more recent studies provide evidence that diet and exercise can improve hypertension, the findings of the older study may not presently apply.